The Collective of Experts at Devinebio
Devinebio has assembled a Collective of Experts in drug development. They come from a variety of backgrounds and experiences. The Collective of Experts provides us just-in-time solutions - at the right time and place where they are most needed.
Target ID, Drug Discovery, Corporate Relations
iPSC Assay Development, Drug Screens, High Content imaging
Molecular Dynamics Modeling, AI Smart Library Generation
Regulatory Strategy, Drug Development, Health Authority Liaison
Drug Discovery, Neurology and cardiology, Disease Model Creation
Microphysological Systems, Bimedical Engineering, Microfluidics
Immunological Drug Development, Vaccine Therapies in Oncology, iPSC Platforms for Drug Discovery
Priority Review Vouchers, Alternative Funding, Drug Hunting, Startups.
Drug Development GAP assessment, CMC Development and Clinical Pharmacology,
Neurodegeneration models, drug discovery and development
Patents, IP licensing, Dispute Resolution
Neuropharmacology, biomarker development, Statistics
Microfludics, Neuromuscular Junction Models, iPSC-based Systems
Bioprinting, Vascular 3D models, Venture Architect
Data Managment Services, Statistical Analysis Plans, Strategic Planning
Startup Entrepreneur, Life Science Operations, Business Development
CDMO Sourcing and Management, CMC Strategic Roadmaps, Process Improvement
Commercialization Strategy, Asset Partnering, Stakeholder Management
Rare Disease Commercialization, Product Marketing Strategy, Management and Organizational Build
Clinical Study Design, Regulatory Engagement, Global trials management.
Federal Research Projects, Vaccines and Diagnostics Development, Federal Agency Liaison.
The Collective Details
The Collective of Experts team expertise covers Drug-Protein Interaction Modeling, Smart Library Generation, High-throughput and High-content Assay Development, Animal Model Development, FDA Regulatory Filings, Chemistry-Manufacturing-Controls, and Clinical Trials Planning, and more. They help us foster the growth of our Special Purpose Exit Companies (SPECs) where we mature drug assets in a given genetic disease towards market approval. The Collective of Experts also provides efficient drug development solutions for Life Science companies. We aid in commercializing therapeutics for Small Molecules, Biologics and Advanced Therapeutics. This is part of the Devine Process - we accesses expert talent, at the right time, and at the right place of need, to help keep the drug development pipeline on track.
Ready to partner on drug discovery?
Schedule a call with us using the following link: